Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2009 055 917.6 |
96 | EP file number | EAKZ | 09 74 6975.3 |
86 | WO file number | WAKZ | PCT/US2009/002999 |
97 | EP publication number | EPN | 2299984 |
87 | WO publication number | WPN | 2009139888 |
54 | Designation/title | TI | ORALE FORMULIERUNGEN VON CYTIDIN-ANALOGA UND ANWENDUNGSVERFAHREN DAFÜR |
51 | IPC main class | ICM (ICMV) | A61K 9/20 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/28 (2006.01), A61K 31/7068 (2006.01) |
22 | DE application date | DAT | May 14, 2009 |
96 | EP application date | EAT | May 14, 2009 |
86 | WO application date | WAT | May 14, 2009 |
43 | Date of first publication | OT | Nov 19, 2009 |
| Date of publication of grant | PET | Nov 28, 2018 |
71/73 | Applicant/owner | INH | Celgene Corporation, Princeton, NJ, US |
72 | Inventor | IN | ETTER, Jeffrey, B., Boulder CO 80302, US; LAI, Mei, Longmont CO 80504, US; BACKSTROM, Jay, Thomas, Leawood KS 66224, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 157875 P Mar 5, 2009
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201145 P Dec 5, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 53609 P May 15, 2008
|
| Due date | FT FG | May 31, 2026 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, BA |
| Published EP/WO documents | EPWOPN | Original document:
EP000002299984 Searchable text:
EP000002299984 Original document:
EP000002299984B1 Searchable text:
EP000002299984B1 Original document:
WO002009139888 Searchable text:
WO002009139888 |
43 | Date of first publication | EVT | Nov 19, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 10, 2025 (Show all update days)(Hide all update days)- Apr 10, 2025
- Mar 20, 2025
- Procedures: New applicant/owner details, New applicant/owner details, 10.02.2025: changed
- Feb 11, 2025
- Applicant/owner: changed
- Procedures: New applicant/owner details, New applicant/owner details, 10.02.2025: new
- Nov 7, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 26.07.2024: changed
- Oct 3, 2024
- Procedures: Opposition procedure, Patent maintained in full by EPO, 26.07.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 26.07.2024: new
- Jun 9, 2024; Apr 11, 2024; Mar 14, 2024; Apr 8, 2023; Apr 7, 2022; Apr 24, 2021; Jun 5, 2020; Oct 17, 2019; Sep 12, 2019; Aug 16, 2019; Jun 8, 2019; Jan 15, 2019; Dec 20, 2018; Nov 9, 2018; Nov 8, 2018; Oct 29, 2018; Jul 5, 2018; Mar 8, 2018; Nov 10, 2016; Feb 15, 2013; Aug 25, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|